Upadacitinib API (CAS 1310726-60-3) is a potent, selective JAK1 inhibitor indicated for moderate-to-severe rheumatoid arthritis, psoriatic arthritis, and atopic dermatitis. This Upadacitinib is synthesized under strict GMP guidelines, achieving ≥99.5% purity by HPLC. As a China Upadacitinib manufacturer, Cosperpharm guarantees consistent impurity profiles, low residual solvents, and excellent stability. Our Upadacitinib factory operates with ISO 9001:2015 and has passed multiple customer audits. Moreover, Cosperpharm is a licensed pharmaceutical importer and exporter - we handle all customs documentation, making it easy for international buyers to purchase Upadacitinib from China with full compliance.
|
Parameter |
Specification |
|
CAS Number |
1310726-60-3 |
|
Molecular Formula |
C₁₇H₁₉F₃N₆O |
|
Purity (HPLC) |
≥99.5% |
|
Any single impurity |
≤0.10% |
|
Total impurities |
≤0.50% |
|
Particle Size (D90) |
≤20 µm (customizable) |
|
Appearance |
White to off-white powder |
|
Storage |
2-8°C, protected from light |
|
Packaging |
1kg, 5kg, 25kg drums (customizable) |
The above specifications are a comprehensive reference version based on general standards of EMA (Europe) and FDA (USA).
|
Advantage |
Details |
|
Production Strength |
GMP-certified workshop, 500kg annual production capacity for Upadacitinib API. Multi-step synthesis with in-process HPLC monitoring. |
|
Fast Delivery |
Stocked R&D samples ship within one week; commercial orders: one to two months after payment. Express (DHL/FedEx) or air/sea freight available. |
|
Global Partners |
Trusted by 30+ pharmaceutical companies in USA, Europe, India, Brazil, and Southeast Asia. Long-term cooperation with generic drug manufacturers and CROs. |
|
Licensed Exporter |
Valid drug import/export license – no compliance delays. |
`High purity & low impurities – suitable for oral solid dosage forms.
`Customized particle size – optimize your tablet dissolution.
`Valid export license – Cosperpharm is an authorized Upadacitinib exporter.
Indications: Rheumatoid arthritis, psoriatic arthritis, atopic dermatitis, ankylosing spondylitis, ulcerative colitis.
Cosperpharm manufactures Upadacitinib API in a modern GMP workshop. Each batch undergoes HPLC, GC, LC-MS, residual solvent (ICH Q3C), heavy metals, and genotoxic impurity testing. We provide full traceability from raw material to final API.
Q1: What is your MOQ for Upadacitinib API?
A: R&D samples: 10g. Commercial orders: 1kg. Larger quantities available upon request.
Q2: What is your typical lead time?
A: In-stock R&D samples: within one week. Bulk orders: one to two months after payment confirmation.
Q3: Which countries have you exported to?
A: USA, Canada, Germany, UK, Spain, India, Brazil, South Korea, Japan, and more. We have experience with local customs and regulatory requirements.
Q4: Can you provide third-party testing or audit?
A: Yes. We welcome customer audits or SGS/BV inspections. Third-party testing can be arranged at buyer’s cost.
Q5: What certificates do you hold?
A: GMP certificate (ISO 9001:2015), pharmaceutical import/export license, and COA for each batch.
Q6: Do you offer customized packaging?
A: Yes. We can customize packaging size, labeling, and even inner lining materials per your request.
Ready to buy Upadacitinib API? Contact Cosperpharm today for a sample or quote. We look forward to becoming your long-term China Upadacitinib supplier.
Address
No. 2 Yangguang 3rd Road, Duodao Chemical Cycle Industrial Park, Jingmen City, Hubei Province, China
Tel
